Navigation Links
Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
Date:10/16/2009

IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its third quarter 2009 financial results, which will take place on Tuesday, October 27, 2009 after the close of the market.

Endologix will hold a conference call on Tuesday, October 27, 2009 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for domestic callers and (201) 689-8562 for international callers. A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate website at www.endologix.com.

After the live Web cast, the call will remain available on Endologix's Web site, www.endologix.com, through November 27, 2009. In addition, a telephonic replay of the call will be available until November 3, 2009. The replay dial-in numbers are (877) 660-6853 for domestic callers and (201) 612-7415 for international callers. Please use account number 3055 and conference ID number 335438.

About Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can
'/>"/>

SOURCE Endologix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., , INDIANAPOLIS, Dec. 4 /PRNewswire-...ion (FDA) today approved Zyprexa® (olanzapine... schizophrenia and manic or mixed episodes associa...-17 years old. ,, The updated Zyprexa label st...n the increased potential for weight gain and hype...
(Date:12/4/2009)..., , OMAHA, Neb., Dec. 4 Am...editation by the Accreditation Commission for Heal...ices. For nearly 15 years, Amber Pharmacy has prov...ices to meet the unique needs of specialized condi...ers of services to transplant programs. They work ...
(Date:12/4/2009)..., , STREAMWOOD, Ill., Dec. 4 /PRNewswire/...f CT, MRI and PET/CT systems and service programs ... to announce it has received The Joint Commission,...onally-recognized, prestigious gold seal of approv...Imaging accreditation is system-wide for its mobil...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Gut worms may protect against house dust mite allergy 58400 1Gut worms may protect against house dust mite allergy 58400 2Gut worms may protect against house dust mite allergy 58400 3Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 1Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 2Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 3Canker disease in eucalyptus in the Basque Country 10128 1Canker disease in eucalyptus in the Basque Country 10128 2Canker disease in eucalyptus in the Basque Country 10128 3Canker disease in eucalyptus in the Basque Country 10128 4
... ANTIPOLIS, France, Nov. 7 NicOx S.A.,(Eurolist: ...xploratory,pharmacodynamic study for naproxcinod u...ere presented yesterday at the American Heart,Asso...ida. Naproxcinod is,the first compound in the COX-...ammatory agents and is in clinical development for...
..., Nov. 7 Vital Therapies, Inc. (VTI), announced,t...) (Extracorporeal Liver,Assist Device) System were...e Study of Liver Diseases (AASLD) Annual Meeting, ...Abstract (#91), "Interim results of Randomized Con...Liver Disease," was presented in a parallel s...
Other Medicine Technology:NicOx' Naproxcinod ABPM Data Presented at American Heart Association 2NicOx' Naproxcinod ABPM Data Presented at American Heart Association 3NicOx' Naproxcinod ABPM Data Presented at American Heart Association 4Vital Therapies Announces Presentation of ELAD(R) 'Artificial Liver' Data at American Association for the Study of Liver Diseases 2007 Annual Meeting 2
(Date:12/4/2009)...irstCall/ -- Care Investment Trust Inc. (NYSE: ...hat its Board of Directors has declared a dividend... is payable on December 22, 2009 to common shareho...out Care Investment Trust ,, Care Investment T...company investing in healthcare-related real estat...
(Date:12/4/2009)...swire/ -- Medithrive, Inc. has won the Patient,s C...ay Area by popular vote conducted by the online we...hs in operation, the SF Bay community has selected...ng medicinal marijuana. ,, The rapid rise and...dispensary which caters to the consumer, provides ...
(Date:12/4/2009)...-USNewswire/ -- The American Association of Homes ...nate for ensuring that the Community Living and S...e final health reform legislation . The CLASS prov...rs, people with disabilities and their caregivers....eform bill that will make it affordable to care fo...
(Date:12/4/2009)...Newswire/ -- The large, two-day free health clinic...nics (NAFC) in Kansas City on Wednesday and Thursd...o is uninsured and has not seen a doctor recently....e preventive primary care. ,, "Many people who...nts this fall in Houston, New Orleans and Little R...
(Date:12/4/2009)...Newswire/ -- Pamela Bowen, Chief Information Offic...ist for the "Chief Innovation Officer" Appy Award ...r of cloud computing. Appy Award recipients are no...rce CRM or the Force.com platform in bringing new ...ng, partner, service, support or IT organizations....
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
..., The Association for Gerontology in Higher Educ...ntological Society of America , will hold its 35t...ence February 26March 1, 2009, at the Crowne Pla... about gerontological and geriatric education and ...
..., CARLSBAD, Calif., Jan. 30 Beautiful skin wi...you may actually save money on skin care,this year...tress level and,cleaning out your cabinets. , ...skin. With the ten thrifty tips, this host of "Ski...
..., RED BANK, New Jersey, BRUSSELS and MELBOURNE...obal corporate,website. With over a century of exp...otective solutions is now rethinking its presence ... The site includes corporate information with ...
..., Three New Studies Initiated in Other Oncology Se...0 GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN)...ense Application (BLA) to the U.S. Food and Drug A...erapies. If approved, ofatumumab would be the firs...
..., SAN DIEGO and LISLE, Ill., Jan. 30 SpineMar...that partners with hospitals and,physicians to dev... a,partnership with Healthplace America to deliver...Surgery Benefit(TM). As a result,of their affilia...
..., MIAMI, Jan. 30 Physicians Healthcare Managemen...developer of health maintenance organizations (HMO...hyshield Insurance Exchange, a licensed medical ma...ongress and a new administration in Washington. H...
Other Medicine News:Health News:Teaching about financial crisis among Gerontology Meeting's highlights 2Health News:Ten Thrifty Tips for Radiant Skin 2Health News:Ten Thrifty Tips for Radiant Skin 3Health News:Ansell Limited Launching a New Global Website 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 3Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 4Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 5Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 6Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 7Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 8Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 2Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 3Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 4Health News:Phyhealth Provides Update to Shareholders 2Health News:Phyhealth Provides Update to Shareholders 3Health News:Phyhealth Provides Update to Shareholders 4
AGC Revision knee
Advance Stemmed Medial-Pivot Knee
AGC Dual Articular Knee
Scorpio TS Single Axis Revision Knee System
Medicine Products: